July 2021
Core topics in this month’s edition include:
- Chantix (varenicline) - recall and shortage update
- Semglee (insulin glargine-yfgn) - new interchangeable biosimilar
- Olumiant (baricitinib) - emergency use authorization expansion
- REGEN-COV (casirivimab/imdevimab) - emergency use authorization expansion
Top